Standout Papers

Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial 2013 2026 2017 2021 725
  1. Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial (2013)
    Mark R. Gilbert, Meihua Wang et al. Journal of Clinical Oncology

Immediate Impact

3 by Nobel laureates 3 from Science/Nature 58 standout
Sub-graph 1 of 21

Citing Papers

Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia
2024 Standout
Glioblastoma and Other Primary Brain Malignancies in Adults
2023 Standout
8 intermediate papers

Works of Minhee Won being referenced

Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors
2022
Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
2013 Standout
and 7 more

Author Peers

Author Last Decade Papers Cites
Minhee Won 1905 1340 515 624 62 3.4k
Bettina Hentschel 1944 888 506 735 82 3.7k
R. D. T. Jenkin 1580 1269 894 541 57 4.2k
Vinai Gondi 2140 3073 1533 815 133 4.3k
Kathryn E. Dusenbery 519 969 1055 458 122 4.4k
Masato Kochi 2042 644 458 529 85 4.4k
Ufuk Abacıoğlu 2518 2793 1509 994 65 4.3k
Berthold Streubel 1466 856 1911 389 148 6.3k
Carmen Balañá 1213 819 752 245 119 2.6k
Chu H. Chang 2663 1898 893 817 48 4.3k
Urs M. Lütolf 1090 1328 670 260 50 3.4k

All Works

Loading papers...

Rankless by CCL
2026